ATOM
The AI engine Fit Assessment
BetaATOM leverages machine learning and data-driven modeling to enhance drug discovery, focusing on developing new therapeutics and optimizing the drug design process.
Blurb
ATOM is a public-private partnership with the mission of transforming drug discovery by accelerating.
HQ Location
San Francisco (United States)
Founded
2017
Employees
11 - 50
Total funding raised
Not available
Funding Status
Not available
Subspaces
- Drug Discovery Optimization
The Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium is a public-private partnership with the mission of transforming drug discovery by accelerating the development of more effective therapies for patients.